share_log

Ginkgo Bioworks | DEF 14A: Definitive information statements

SEC announcement ·  Apr 29 16:06
Summary by Moomoo AI
Ginkgo Bioworks Holdings, Inc. (Ginkgo) has announced its 2024 Annual Meeting of Shareholders to be held virtually on June 13, 2024. The meeting will allow shareholders to participate online and vote electronically. The proxy statement accompanying the notice outlines the business to be considered at the meeting, which includes the election of nine director nominees, the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and the approval of executive compensation. Shareholders as of the record date, April 16, 2024, are entitled to vote. The proxy materials and Ginkgo's 2023 Annual Report are available at www.proxyvote.com. The Board of Directors recommends voting for each director nominee and for the ratification of the appointment of Deloitte & Touche LLP. The meeting will also address the election of Class B Directors, the approval of executive compensation, and other business as may arise.
Ginkgo Bioworks Holdings, Inc. (Ginkgo) has announced its 2024 Annual Meeting of Shareholders to be held virtually on June 13, 2024. The meeting will allow shareholders to participate online and vote electronically. The proxy statement accompanying the notice outlines the business to be considered at the meeting, which includes the election of nine director nominees, the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and the approval of executive compensation. Shareholders as of the record date, April 16, 2024, are entitled to vote. The proxy materials and Ginkgo's 2023 Annual Report are available at www.proxyvote.com. The Board of Directors recommends voting for each director nominee and for the ratification of the appointment of Deloitte & Touche LLP. The meeting will also address the election of Class B Directors, the approval of executive compensation, and other business as may arise.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more